E. Magnus Ohman, MD: Hello. I am Magnus Ohman, and I am here with Dr P.K. Shah from Cedars-Sinai in Los Angeles. We actually met a long time ago, and it was a memorable meeting for me. We were in a meeting in São Paulo, Brazil. It was in the 1990s, and we were sitting there, and you said, "I am working on creating a vaccine for atherosclerosis." I said, "Wow, that is something to start with." Obviously, most of us think that somebody who takes that on must have had a very unique life. This series is called Life and Times of Leading Cardiologists. It is about your life and what made you tick and why you took on such a challenge as this. Welcome.
I had thought of becoming a detective because I used to read Arthur Conan Doyle and Agatha Christie all the time.
Prediman K. Shah, MD: Well, thank you very much, Magnus.
Dr Ohman: Where did you actually grow up?
Dr Shah:I was born in Srinagar, Kashmir, in North India, and I was one of eight children and the only one who went to medical school. My motivation for going to medical school was triggered by the very tragic death of one of my sisters, who was 19 at the time.
COMMENTARY
Life and Times of Leading Cardiologists: P.K. Shah
Interviewer: E. Magnus Ohman, MD; Interviewee: Prediman K. Shah, MD
DisclosuresMay 03, 2017
E. Magnus Ohman, MD: Hello. I am Magnus Ohman, and I am here with Dr P.K. Shah from Cedars-Sinai in Los Angeles. We actually met a long time ago, and it was a memorable meeting for me. We were in a meeting in São Paulo, Brazil. It was in the 1990s, and we were sitting there, and you said, "I am working on creating a vaccine for atherosclerosis." I said, "Wow, that is something to start with." Obviously, most of us think that somebody who takes that on must have had a very unique life. This series is called Life and Times of Leading Cardiologists. It is about your life and what made you tick and why you took on such a challenge as this. Welcome.
Prediman K. Shah, MD: Well, thank you very much, Magnus.
Dr Ohman: Where did you actually grow up?
Dr Shah:I was born in Srinagar, Kashmir, in North India, and I was one of eight children and the only one who went to medical school. My motivation for going to medical school was triggered by the very tragic death of one of my sisters, who was 19 at the time.
© 2017 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Life and Times of Leading Cardiologists: P.K. Shah - Medscape - May 03, 2017.
Tables
Authors and Disclosures
Authors and Disclosures
Interviewer
E. Magnus Ohman, MD
Professor of Medicine, Division of Cardiovascular Medicine; Vice-Chair, Department of Medicine, Development and Innovation; Kent and Siri Rawson Director, Duke Program for Advanced Coronary Disease; Associate Director, Duke Heart Center, Duke University Medical Center, Durham, North Carolina
Disclosure: E. Magnus Ohman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: ABIOMED; AstraZeneca Pharmaceuticals LP; Biotie Therapies; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo; Faculty Connection, LLC; Stealth Peptides; The Medicines Company; Medscape
Received research grant from: Daiichi Sankyo; Gilead Sciences Inc; Janssen Pharmaceutical Products, L.P.
Received income in an amount equal to or greater than $250 from: ABIOMED; AstraZeneca Pharmaceuticals LP; Biotie Therapies; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo; Faculty Connection, LLC; Gilead Sciences Inc; Janssen Pharmaceutical Products, L.P.; Stealth Peptides; The Medicines Company; Medscape
Interviewee
Prediman K. Shah, MD, FACC, FACP, FCCP
Professor of Medicine, David Geffen School of Medicine at University of California Los Angeles; Shappell and Webb Family Chair in Clinical Cardiology; Director, Oppenheimer Atherosclerosis Research Center & Atherosclerosis Prevention & Treatment Center and Steven S. Cohen Fellowship Program, Cedars-Sinai Heart Institute, Los Angeles, California
Disclosure: Prediman K. Shah, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Cardiovax (co-founder)
Received research grant from: Amgen Inc.; sanofi-aventis; Regeneron Pharmaceuticals, Inc.